Zepbound

GLP-1 drugs: clinical trends, safety, and market shifts

315 clusters · 1160 sources · last updated about 7 hours ago

Latest: GLP-1 weight loss drugs drive surge in protein-based products

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. A large-scale U.S. study sug

Novo Nordisk pivots strategy to counter patent cliff

112 clusters · 548 sources · last updated 3 days ago

Latest: Novo Nordisk faces intense competition in obesity drug market

Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated 4 days ago

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

Eli Lilly retatrutide development and black market issues

11 clusters · 32 sources · last updated 16 days ago

Latest: Incretin agonists show potential in obesity treatment amid safety concerns

In early August 2026, Eli Lilly announced that its experimental obesity treatment retatrutide achieved substantial weight-loss outcomes in two phase-3 trials. Participants lost up to 22.6% of body weight over 80 weeks in

Eli Lilly market growth and pharmaceutical expansion

4 clusters · 6 sources · last updated 22 days ago

Latest: Eli Lilly sees increased institutional investment and pipeline growth

Eli Lilly has experienced significant financial growth and market recognition driven by its diabetes and weight-loss medication portfolio. Analysts have issued upgrades and high price targets, with Citigroup setting a $1

Dr. Ian Smith menopause nutrition guidance

2 clusters · 12 sources · last updated 25 days ago

Latest: Dr. Ian Smith discusses menopause nutrition and weight loss

Dr. Ian Smith has released a new book, ‘The New Menopause Kitchen: Targeted Nutrition to Help Fight Symptoms, Lose Weight, and Thrive in Perimenopause, Menopause, and Beyond’. The work was developed in response to reques